Home/Filings/4/0000899243-22-004185
4//SEC Filing

Horga Maria Arantxa 4

Accession 0000899243-22-004185

CIK 0001593899other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:15 PM ET

Size

5.4 KB

Accession

0000899243-22-004185

Insider Transaction Report

Form 4
Period: 2022-01-31
Horga Maria Arantxa
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-31+170,000170,000 total
    Exercise: $7.14Exp: 2032-01-30Common Stock (170,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.

Issuer

Atea Pharmaceuticals, Inc.

CIK 0001593899

Entity typeother

Related Parties

1
  • filerCIK 0001829614

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:15 PM ET
Size
5.4 KB